Mistretta Virginie, Kurth William, Charlier Corinne
Service de toxicologie clinique, médico-légale, de l'environnement et en entreprise, CHU Sart-Tilman, 1 avenue de l'Hôpital, 4000 Liège, Belgique.
Service de chirurgie de l'appareil locomoteur, CHU Sart-Tilman, 1 avenue de l'Hôpital, 4000 Liège, Belgique.
Med Sci (Paris). 2016;32(8-9):732-8. doi: 10.1051/medsci/20163208021. Epub 2016 Sep 12.
The placement of a hip prosthesis is one of the most common orthopedic surgical procedures. Some implants contain metal and are therefore capable of releasing metal particles like cobalt in patients who wear metal prostheses. Cobalt can be responsible of local toxicity (including metallosis, hypersensitivity reaction, and benign tumor) or systemic toxicity (including cardiomyopathy, polycythemia, hypothyroidism, and neurological disorders). To monitor potential toxicity of metal hip prostheses, an annual monitoring of patients implanted is recommended and includes clinical examination, radiological examination and blood cobalt determination. The cobalt concentration in blood allows to estimate the risk of toxicity and to evaluate the performance of the implant. The currently recommended threshold value is equal to 7 µg of cobalt per liter of blood. Our study, conducted on 251 patients over a period of 4 years, has shown that the cobalt concentration average was 2.51 µg/l in blood, with 51 patients having a cobaltemia higher than the threshold of 7 µg/l.
髋关节假体植入是最常见的骨科手术之一。一些植入物含有金属,因此在佩戴金属假体的患者体内能够释放出钴等金属颗粒。钴可能导致局部毒性(包括金属沉着症、过敏反应和良性肿瘤)或全身毒性(包括心肌病、红细胞增多症、甲状腺功能减退和神经紊乱)。为监测金属髋关节假体的潜在毒性,建议对植入患者进行年度监测,包括临床检查、放射学检查和血液钴含量测定。血液中的钴浓度有助于评估毒性风险和植入物的性能。目前推荐的阈值是每升血液中钴含量等于7微克。我们在4年时间里对251名患者进行的研究表明,血液中钴浓度平均为2.51微克/升,有51名患者的血钴水平高于7微克/升的阈值。